AXSOME THERAPEUTICS, INC. (AXSM) Operating margin 2022–2025
AXSOME THERAPEUTICS, INC. (AXSM) operating margin by fiscal year — reported operating income divided by reported revenue.
-26.1%FY2025 · since FY2022: -359.3% → -26.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -26.1% | +46.6 pp |
| FY2024 | -72.7% | +12.9 pp |
| FY2023 | -85.7% | +273.7 pp |
| FY2022 | -359.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AXSM financial trends
AXSM RevenueAXSM Net incomeAXSM Net marginAXSM Gross profitAXSM Gross marginAXSM Operating incomeAXSM Operating cash flowAXSM Free cash flowAXSM Capital expendituresAXSM Return on equityAXSM Stock buybacksAXSM Dividends paidAXSM Total assetsAXSM Total liabilitiesAXSM Shareholders’ equityAXSM overview →